| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/08/2008 | US7354901 Production of recombinant BMP-2 |
| 04/08/2008 | US7354766 Modification of plant crossing properties via gene transfer |
| 04/08/2008 | US7354765 Soybean plants with enhanced expression of daidzein and genistein; for use in improving nutrient quality of foods |
| 04/08/2008 | US7354761 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance |
| 04/08/2008 | US7354760 Expression of protective antigens in transgenic chloroplasts |
| 04/08/2008 | US7354759 Induce immunology response; antiproliferation agents; coding immoglobulins |
| 04/08/2008 | US7354756 Expression of nucleic acid produces polypeptide which spontaneously splices in host to yield a cyclized form; catalyzes formation of aminosuccinimide; useful in drug screening |
| 04/08/2008 | US7354755 Transposon for use as genetic engineering tool for stable insertion of exogenous genes into a bacterial genome |
| 04/08/2008 | US7354753 Amino acid alterations; improved thermal stability and/or increased specific activity; use in conversion of starch, producing maltodextrins, glucose syrups, fuel, beverages and in fermentation |
| 04/08/2008 | US7354752 Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions |
| 04/08/2008 | US7354751 Alcohol dehydrogenase gene of acetic acid bacterium |
| 04/08/2008 | US7354741 transferring N-acetylgalactosamine and N-acetylglucosamine using soluble protein; DNA can be used as probe for hybridization |
| 04/08/2008 | US7354739 Modulation contraction of stomach tissue; gastrointestinal disorders; applying peptide |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354728 Coactivation of nuclear receptors |
| 04/08/2008 | US7354726 Identifying modulators of g protein coupled receptor activity for diagnosing, treating and preventing disorders associated with cholesterol metabolism, cancer, infections and inflammation |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354718 Molecular dissection method using trans-splicing to designed spliced leader sequences, genes, and constructs thereof |
| 04/08/2008 | US7354717 Kit comprising hhybrid RNA/DNA primer strand for use in isothermal replication/propagation of RNA polynucleotides |
| 04/08/2008 | US7354710 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 04/08/2008 | US7354709 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer |
| 04/08/2008 | US7354708 Invasion assays |
| 04/08/2008 | US7354594 Merozoite surface protein 1 lacking glycosylation sites |
| 04/08/2008 | US7354592 Administering mutant Salmonella sp. for therapy of solid tumor cancer, disrupted msbB gene and is capable of targeting a solid tumor cancer |
| 04/08/2008 | US7354591 Poxvirus with targeted infection specificity |
| 04/08/2008 | US7354588 Organ transplantation, tissue grafting, allergy, oncology, diagnosis, therapy |
| 04/08/2008 | US7354586 Treating arthritis by administering a therapeutically effective amount of an antibody immunospecific for av beta 3; antiarthritic agents;anticarcinogenic agents; antitumor agents; antimetastasis agents; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3 |
| 04/08/2008 | US7354585 Methods of treating coagulapathic or thrombotic disorders |
| 04/08/2008 | US7354583 Antibody-induced apoptosis |
| 04/08/2008 | US7354582 Use of VEGF antagonists for the treatment of malignant gliomas |
| 04/08/2008 | US7354581 For treating a disease or condition related to angiogenesis |
| 04/08/2008 | US7354580 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 04/08/2008 | US7354579 Method of treating cancer with a VEGF antagonist and an anti-proliferative agent |
| 04/08/2008 | US7354578 Method of tumor regression with VEGF inhibitors |
| 04/08/2008 | US7354577 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
| 04/08/2008 | US7354576 Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase |
| 04/08/2008 | US7354390 Probes derived from the cDNA or genomic DNA used to detect polymorphisms that distinguish EpEp and epep genotypes; control expression of genes encoding herbicide resistance, biological control of insects or pathogens, viral coat proteins to protect against viral infections |
| 04/08/2008 | CA2448318C Compositions and methods of increasing stress tolerance in plants |
| 04/08/2008 | CA2414788C Acetate-free purification of plasmid dna on hydroxyapatite |
| 04/08/2008 | CA2382593C Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use |
| 04/08/2008 | CA2305013C Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/08/2008 | CA2253838C Dp and e2f protein nuclear localisation signals and their use |
| 04/08/2008 | CA2205082C Method of forming double stranded dna polymer having repeating subunits in tandem |
| 04/08/2008 | CA2169171C New growth/differentiation factor of the tgf-beta family |
| 04/08/2008 | CA2143104C Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 04/08/2008 | CA2136564C Process for producing human serum albumin |
| 04/08/2008 | CA2130454C Production of viral resistant plants via introduction of untranslatable plus sense viral rna |
| 04/08/2008 | CA2124967C Transgenic non-human animals capable of producing heterologous antibodies |
| 04/08/2008 | CA2122732C Multivalent antigen-binding proteins |
| 04/08/2008 | CA2111006C A novel receptor-type tyrosine kinase and use thereof |
| 04/07/2008 | WO2008043765A1 Thermus eggertssonii dna polymerases |
| 04/03/2008 | WO2008040017A2 Eukaryotic cells expressing (sid-i) for gene screening |
| 04/03/2008 | WO2008039980A2 Apoptotic cell-mediated transfection of mammalian cells with interfering rna |
| 04/03/2008 | WO2008039937A2 Blocking of gene expression in eukaryotic cells |
| 04/03/2008 | WO2008039932A1 Rapid in vivo model for angiogenesis |
| 04/03/2008 | WO2008039709A2 The maize erecta genes for improving plant growth, transpiration efficiency and drought tolerance in crop plants |
| 04/03/2008 | WO2008039669A1 Nucleic acid purification method |
| 04/03/2008 | WO2008039668A1 Nucleic acid purification method |
| 04/03/2008 | WO2008039664A1 Nucleic acid purification method using anion exchange |
| 04/03/2008 | WO2008039538A2 Compositions of tlr ligands and antivirals |
| 04/03/2008 | WO2008039370A1 Acetolactate synthase (als) selectable marker from trichoderma reesei |
| 04/03/2008 | WO2008039357A2 Uncoupling of dna insert propagation and expression of protein for phage display |
| 04/03/2008 | WO2008039254A2 Rna nanoparticles and nanotubes |
| 04/03/2008 | WO2008038845A1 Attenuated recombinant newcastle disease virus and vaccine containing the same |
| 04/03/2008 | WO2008038833A1 Method for determination of dna methylation |
| 04/03/2008 | WO2008038696A1 Method of assaying target substance in sample, aptamer molecule and method of constructing the same |
| 04/03/2008 | WO2008038630A1 Method for high-level production of protein by utilizing atf4 and/or gadd34 |
| 04/03/2008 | WO2008038613A1 Method for production of dipeptide |
| 04/03/2008 | WO2008038600A1 1,4-benzodiazepine derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 04/03/2008 | WO2008038587A1 Cd20-negatively converted b cell malignant lymphocyte cell line and utilization of the same |
| 04/03/2008 | WO2008038579A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 04/03/2008 | WO2008038507A1 Substratum and method of reactive liquid reaction |
| 04/03/2008 | WO2008038267A2 Use of antisense oligonucleotides against cpla2 in the treatment of cancer |
| 04/03/2008 | WO2008038138A1 Optimal method for recombinant production of a marine metalloprotein and uses thereof |
| 04/03/2008 | WO2008038062A1 Target genes for strain-specific diagnostic of ehrlichia ruminantium and use thereof |
| 04/03/2008 | WO2008037735A1 Method for making maturated insulin polypeptides |
| 04/03/2008 | WO2008037732A1 Plant cell lines established from the medicinal plant veratrum californicum |
| 04/03/2008 | WO2008037492A1 Galactosyltransferase |
| 04/03/2008 | WO2008037490A2 Galactosyltransferase |
| 04/03/2008 | WO2008037458A2 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening |
| 04/03/2008 | WO2008037436A1 Methods and means for removal of a selected dna sequence |
| 04/03/2008 | WO2008037431A1 Transcriptional repressors of cytokinin signaling and their use |
| 04/03/2008 | WO2008037419A1 Antibodies against ccr5 and uses thereof |
| 04/03/2008 | WO2008037265A2 Method of fed-batch cultivation and recombinant protein expression in escherichia coli bl21(de3) in deuterated medium |
| 04/03/2008 | WO2008037123A1 Recombinant periplaneta fuliginosa densovirus and use thereof |
| 04/03/2008 | WO2008037080A1 Methods and compositions for immune response modulation and uses thereof |
| 04/03/2008 | WO2008037043A1 The process of production and purification of recombinant gp43 (rgp43) isoforms in the yeast pichia pastoris, use of rgp43 and diagnostic kit |
| 04/03/2008 | WO2008020293A3 West nile virus envelope (e) protein antigen and immunoassay |
| 04/03/2008 | WO2008019290A3 Human antibodies to erbb 2 |
| 04/03/2008 | WO2008019142A3 Oligonucleotide systems for targeted intracellular delivery |
| 04/03/2008 | WO2008018790A3 Quality control of agricultural products based on gene expression |
| 04/03/2008 | WO2008018789A3 Methods and means for diagnosing and treatment of osteoarthritis |
| 04/03/2008 | WO2008018642A3 Genes and polypeptides relating to breast cancers |
| 04/03/2008 | WO2008016391A3 Self-complementary parvoviral vectors, and methods for making and using the same |
| 04/03/2008 | WO2007146980A3 Improved epsp synthases: compositions and methods of use |
| 04/03/2008 | WO2007141346A3 Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases |
| 04/03/2008 | WO2007139898A3 Variant foki cleavage half-domains |
| 04/03/2008 | WO2007137679A3 Device and substance for isolating mesenchymal stem cells (msc) |